Literature for MK-2748 (S29.001 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2015
1. Rudd,M.T., Butcher,J.W., Nguyen,K.T., McIntyre,C.J., Romano,J.J., Gilbert,K.F., Bush,K.J., Liverton,N.J., Holloway,M.K., Harper,S., Ferrara,M., DiFilippo,M., Summa,V., Swestock,J., Fritzen,J., Carroll,S.S., Burlein,C., DiMuzio,J.M., Gates,A., Graham,D.J., Huang,Q., McClain,S., McHale,C., Stahlhut,M.W., Black,S., Chase,R., Soriano,A., Fandozzi,C.M., Taylor,A., Trainor,N., Olsen,D.B., Coleman,P.J., Ludmerer,S.W. and McCauley,J.A.
   P2-Quinazolinones and bis-macrocycles as new templates for next-generation hepatitis C virus NS3/4a protease inhibitors: discovery of MK-2748 and MK-6325
   ChemMedChem10, 727-735. PubMed  Europe PubMed DOI  I